Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
P. Backhaus, M. C. Burg, I. Asmus, M. Pixberg, F. Büther, H.-J. Breyholz, R. Yeh, S. Weigel, P. Stichling, W. Heindel, S. Bobe, P. Barth, J. Tio, M. Schäfers
J Nucl Med. 2023 May;64(5):717-723. doi: 10.2967/jnumed.122.264871. Epub 2022 Nov 17.
Breast Cancer Detection: Digital Breast Tomosynthesis with Synthesized Mammography versus Digital Mammography
Su Min Ha, Jung Min Chang
Radiology. 2023 Dec;309(3):e232911. doi: 10.1148/radiol.232911.
Breast Density and Breast Cancer Screening with Digital Breast Tomosynthesis: A TOSYMA Trial Subanalysis
S. Weigel*, W. Heindel*, H.W. Hense, T. Decker, J. Gerß, L. Kerschke, for the TOSYMA Screening Trial Study Group *S.W. and W.H. contributed equally to this work.
Radiology. 2023 Feb;306(2):e221006. doi: 10.1148/radiol.221006. Epub 2022 Oct 4.
Lessons Learned from the Randomized Controlled TOmosynthesis plus SYnthesized MAmmography (TOSYMA) Trial
Cindy S. Lee, Linda Moy
Radiology. 2023 Feb;306(2):e222178. doi: 10.1148/radiol.222178. Epub 2022 Oct 4.
Erste Ergebnisse zur multizentrischen, randomisierten, kontrollierten Brustkrebs-Diagnostikstudie ToSyMa
W. Heindel , S. Weigel
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2022; 18(02): 125-126; DOI: 10.1055/a-1826-6228
Surrogate endpoints in breast cancer screening trials - Authors' Reply
W. Heindel, S. Weigel, H.W. Hense
Lancet Oncol. 2022 Aug;23(8):e361. doi: 10.1016/S1470-2045(22)00396-5.